11.84USD+12.43%Mkt Cap: 196.69M USDP/E: 4.17Last update: 2026-06-01
Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immu…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap196.69M USD
Enterprise Value150.60M USD
Revenue (TTM)53.74M USD
Gross Profit38.49M USD
Net Income (TTM)29.82M USD
Revenue/Share4.206 USD
Last Price11.84 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees22
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)4.17
P/E (Forward)-2.06
PEG—
EV/EBITDA6.92
EV/Revenue2.80
P/S3.49
P/B3.49
EPS (TTM)2.78
EPS (Forward)-5.36
52W Range
1.34589% of range13.15
52W High13.15 USD
52W Low1.345 USD
Profitability
Gross Margin71.62%
Oper. Margin39.84%
EBITDA Margin40.51%
Profit Margin55.49%
ROE70.98%
ROA48.27%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-33.54M USD
CapEx (TTM)—
FCF Margin18.37%
FCF Yield5.02%
Net Debt-37.10M USD
Net Debt/EBITDA-1.70
Balance Sheet
Debt/Equity0.37
Current Ratio5.36
Quick Ratio4.81
Book Value/Sh3.166 USD
Cash/Share2.993 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:18
Split DateMar 26, 2024
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)14.25 USD
Target Range10.00 USD – 20.00 USD
# Analysts4
Ownership
Shares Out.16.96M
Float9.69M
Insiders3.93%
Institutions66.00%
Short Interest
Short Ratio2.0d
Short % Float7.77%
Short % Out.3.73%
Shares Short632.72K
Short (prev mo.)382.35K
Technical
SMA 506.207 (+90.8%)
SMA 2003.889 (+204.4%)
Beta-1.27
S&P 52W Chg27.70%
Avg Vol (30d)1.02M
Avg Vol (10d)2.46M
Technical Indicators
RSI (14)69.0
MACD1.0134
MACD Signal0.4152
MACD Hist.+0.5982
BB Upper10.60 USD
BB Middle6.495 USD
BB Lower2.391 USD
BB Width126.39%
ATR (14)1.166 USD
Vol Ratio (20d)0.80x